In this article we conduct a cost-utility analyses of the CAR T-cell therapy tisagenlecleucel from a health care perspective and societal perspective.
In this article we describe the development and simulation of a decision model for the second-line treatment of acute GvHD.
An Evidence Review Group Evaluation of the NICE Single Technology Appraisal for obinutuzumab in combination with chemotherapy for first-line treatment of advanced follicular lymphoma.
A short paper on how to prepare a systematic literature review of economic evaluations.